Although components of both the canonical and non-canonical NF-κB signaling pathways are activated in a number of malignancies, including lung cancer5–7, studies of NF-κB in cancer have mainly focused on canonical pathway signaling, leaving the non-canonical pathway largely uninvestigated. The gene discussed is NFKB1; the disease is cancer.